Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,416,776
-$86,886 QoQ
Shares Held
11,214
+3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#945
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INDEPENDENT FINANCIAL GROUP, LLC holds $56,487,277 across 13 Drug Manufacturers - General names. GILD ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,511 | $16,205,500 | |
| 2 | ABBV |
AbbVie Inc.
|
47,935 | $12,062,363 | |
| 3 | JNJ |
Johnson & Johnson
|
38,636 | $9,812,384 | |
| 4 | MRK |
Merck & Co., Inc.
|
44,565 | $5,726,602 | |
| 5 | AMGN |
Amgen Inc
|
10,299 | $3,729,473 | |
| 6 | PFE |
Pfizer Inc
|
122,166 | $2,941,757 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
11,214 | $1,416,776 | |
| 8 | BIIB |
Biogen Inc.
|
5,364 | $1,158,945 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,416,776 | 11,214 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,503,662 | 10,789 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,314,299 | 10,708 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $1,235,541 | 11,131 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $1,914,170 | 17,265 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,412,278 | 12,604 | Shares | Sole | 2026-05-19 | |
| 2024-12-31 | $990,668 | 10,725 | Shares | Sole | 2026-06-12 | |
| 2024-09-30 | $1,161,603 | 13,855 | Shares | Sole | 2026-06-12 | |
| 2024-06-30 | $739,958 | 10,785 | Shares | Sole | 2026-06-12 | |
| 2024-03-31 | $744,000 | 10,157 | Shares | Sole | 2026-06-12 | |
| 2023-12-31 | $1,250,227 | 15,433 | Shares | Sole | 2026-06-12 | |
| 2023-09-30 | $1,434,426 | 19,141 | Shares | Sole | 2026-06-12 | |
| 2023-06-30 | $754,977 | 9,796 | Shares | Sole | 2026-06-12 | |
| 2023-03-31 | $886,617 | 10,686 | Shares | Sole | 2026-06-12 | |
| 2022-12-31 | $1,123,347 | 13,085 | Shares | Sole | 2026-06-15 | |
| 2022-09-30 | $831,519 | 13,479 | Shares | Sole | 2026-06-15 | |
| 2022-06-30 | $1,274,522 | 20,620 | Shares | Sole | 2026-06-12 | |
| 2022-03-31 | $818,626 | 13,770 | Shares | Sole | 2026-06-12 | |
| 2021-12-31 | $983,938 | 13,551 | Shares | Sole | 2026-06-15 | |
| 2021-09-30 | $990,822 | 14,185 | Shares | Sole | 2026-06-15 | |
| 2021-06-30 | $930,574 | 13,514 | Shares | Sole | 2026-06-15 | |
| 2021-03-31 | $651,535 | 10,081 | Shares | Sole | 2026-06-15 | |
| 2020-12-31 | $330,916 | 5,680 | Shares | Sole | 2026-06-15 | |
| 2020-09-30 | $437,337 | 6,921 | Shares | Sole | 2026-06-15 | |
| 2020-06-30 | $548,351 | 7,127 | Shares | Sole | 2026-06-15 | |
| 2020-03-31 | $708,650 | 9,479 | Shares | Sole | 2026-06-15 | |
| No filing history on record for this holder in this stock. | ||||||